Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Nice big cup and handle formed ready to break out

<< Previous

Bullboard Posts

Next >>

Comment by michelleb33on Feb 07, 2021 1:43pm

97 Views

Post# 32496180

RE:RE:RE:RE:RE:RE:Nice big cup and handle formed ready to break out

you cant argue with fried chicken head akv. Listen. Its not gonna be 2 dollars end of march. And your pump up doll does not clean herself coming out of the shower. Maybe you will buy an upgraded blow up doll when this hits 2 dollars. But a 100 percent it will not be in march cheers

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading